Skip to main content
SpringerLink
Log in

Assay of Soluble Tumor Necrosis Factor Receptors

  • Protocol
Septic Shock Methods and Protocols

Part of the book series: Methods in Molecular Medicine™ ((MIMM,volume 36))

  • 656 Accesses

Abstract

Over the last decade, numerous basic biological as well as experimental and clinical studies have firmly established the significance of tumor necrosis factor (TNF) as a principal proximal mediator of sepsis (1–4). One of the major insights that has emerged during recent years has been that under physiological circumstances, TNF activity is tightly controlled and locally restricted. In this respect, the soluble TNF receptors (sTNF-Rs) have been recognized to exert an important regulatory control on the biological actions of TNF, not only in the normal host defense against infection, but also in systemic inflammatory disorders that are related to infectious as well as noninfectious etiologies. Moreover, elevated systemic levels of sTNF-R have been demonstrated to have accurate diagnostic as well as prognostic significance in clinical sepsis and other critical illnesses (5–13). Therefore, accurate determination of sTNF-R in plasma or serum has become an important tool to gain information about a variety of pathological conditions that are characterized by TNF-mediated immune activation, both in the experimental and in the clinical setting.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Log in via an institution
Protocol
USD 49.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 119.00
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 159.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info
Hardcover Book
USD 159.99
Price excludes VAT (USA)
  • Durable hardcover edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

Similar content being viewed by others

References

  1. Bemelmans, M. H. A., Van Tits, L. J. H., and Buurman, W. A. (1996) Tumor necrosis factor: function, release and clearance. Crit. Rev. Immunol. 16, 1–11.

    CAS  PubMed  Google Scholar 

  2. Strieter, R. M., Kunkel, S. L., and Bone, R. C. (1993) Role of tumor necrosis factor-α in disease states and inflammation. Crit. Care Med. 21, S447–S463.

    Article  CAS  PubMed  Google Scholar 

  3. Tracey, K. J. and Cerami, A. (1993) Tumor necrosis factor: an updated review of its biology. Crit. Care Med. 21, S415–S422.

    Article  CAS  PubMed  Google Scholar 

  4. Beutler, B. and Grau, G. E. (1993) Tumor necrosis factor in the pathogenesis of infectious diseases. Crit. Care Med. 21, S423–S435.

    Article  CAS  PubMed  Google Scholar 

  5. Girardin, E., Roux-Lombard, P., Grau, G. E., Suter, P., Galati, H., and Dayer, J. M. (1992) Imbalance between tumour necrosis factor-a and soluble TNF receptor concentrations in severe meningococcocaemia. Immunology 76, 20–23.

    CAS  PubMed  Google Scholar 

  6. Cinat, M. E., Waxman, K., Granger, G. A., Pearce, W., Annas, C., and Daughters, K. (1994) Trauma causes sustained elevation of soluble tumor necrosis factor receptors. J. Am. Coll. Surg. 179, 529–537.

    CAS  PubMed  Google Scholar 

  7. Rogy, M. A., Coyle, S. M., Oldenburg, H. S., Rock, C. S., Barie, P. S., Van Zee, K. J., Smith, C. G., Moldawer, L. L., and Lowry, S. F. (1994) Persistently elevated soluble tumor necrosis factor receptor and interleukin-1 receptor antagonist levels in critically ill patients. J. Am. Coll. Surg. 178, 132–138.

    CAS  PubMed  Google Scholar 

  8. Kaufmann, P., Tilz, G. P., Lueger, A., and Demel, U. (1997) Elevated plasma levels of soluble tumor necrosis factor receptor (sTNFRp60) reflect severity of acute pancreatitis. Intensive Care Med. 23, 841–848.

    Article  CAS  PubMed  Google Scholar 

  9. Froon, A. H. M., Bemelmans, M. H. A., Greve, J. W., Van der Linden, C. J., and Buurman, W. A. (1994) Increased plasma concentrations of soluble tumor necrosis factor receptors in sepsis syndrome: correlation with plasma creatinine values. Crit. Care Med. 22, 803–809.

    Article  CAS  PubMed  Google Scholar 

  10. Pilz, G., Fraunberger, P., Appel, R., Kreuzer, E., Werdan, K., Walli, A., and Seidel, D. (1996) Early prediction of outcome in score-identified, postcardiac surgical patients at high risk for sepsis, using soluble tumor necrosis factor receptor-p55 concentrations. Crit. Care Med. 24, 596–600.

    Article  CAS  PubMed  Google Scholar 

  11. Van Deuren, M., Van der Ven-Jongekrijg, J., Demacker, P. M. N., Burtelink, A. K. M., Van Dalen, R., Sauerwein, R. W., Gallati, H., Vannice, J. L., and Vander Meer, J. M. M. (1994) Differential expression of proinflammatory cytokines and their inhibitors during the course of meningococcal infections. J. Infect. Dis. 169, 157–161.

    PubMed  Google Scholar 

  12. De Beaux, A. C., Goldie, A. S., Ross, J. A., Carter, D. C., and Fearon, K. C. (1996) Serum concentrations of inflammatory mediators related to organ failure in patients with acute pancreatitis. Br. J. Surg. 83, 349–353.

    Article  PubMed  Google Scholar 

  13. Maessen, J. G., Fransen, E. J., Dentener, M. A., Gorgels, A. P. M., and Buurman, W. A. (1996) Serum soluble TNF receptor as a risk factor in patients with heart failure having cardiac surgery. J. Mol. Cell. Cardiol. 28, Abg (abstract).

    Google Scholar 

  14. Engelberts, I., Möller, A., Schoen, G. J. M., Van der Linden, C. J., and Buurman, W. A. (1991) Evaluation of measurement of human TNF in plasma by ELISA. Lymphokine Cytokine Res. 10, 69–76.

    CAS  PubMed  Google Scholar 

  15. Engelberts, I., Stephens, S., Francot, G. J. M., Van der Linden, C. J., and Buurman, W. A. (1991) Evidence for different effects of soluble TNF-receptors on various TNF measurements in human biological fluids. Lancet 338, 515–516.

    Article  CAS  PubMed  Google Scholar 

  16. Porteu, F. and Nathan, C. (1990) Shedding of tumor necrosis factor receptors by activated human neutrophils. J. Exp. Med. 172, 599–607.

    Article  CAS  PubMed  Google Scholar 

  17. Lantz, M., Björnberg, F., Olsson, I., and Richter, J. (1994) Adherence of neutrophils induces release of soluble tumor necrosis factor receptor forms. J. Immunol. 152, 1362–1369.

    CAS  PubMed  Google Scholar 

  18. Van der Poll, T., Jansen, J., Van Leenen, D., Von der Möhlen, M., Levi, M., Ten Cate, H., Gallati, H., Ten Cate, J. W., and Van Deventer, S. J. (1993) Release of soluble receptors for tumor necrosis factor in clinical sepsis and experimental endotoxemia. J. Infect. Dis. 168, 955–960.

    PubMed  Google Scholar 

  19. Olszyna, D. P., Prins, J. M., Buis, B., Van Deventer, S. J., Speelman, P., and Van der Poll, T. (1998) Levels of inhibitors of tumor necrosis factor alpha and interleukin 1beta in urine and sera of patients with urosepsis. Infect. Immun. 66, 3527–3534.

    CAS  PubMed  Google Scholar 

  20. Mwatha, J. K., Kimani, G., Kamau, T., Mbugua, G. G., Ouma, J. H., Mumo, J., Fulford, A. J., Jones, F. M., Butterworth, A. E., Roberts, M. B., and Dunne, D. W. (1998) High levels of TNF, soluble TNF receptors, soluble ICAM-1, and IFN-gamma, but low levels of IL-5, are associated with hepatosplenic disease in human schistosomiasis mansoni. J. Immunol. 160, 1992–1999.

    CAS  PubMed  Google Scholar 

  21. Bethell, D. B., Flobbe, K., Cao, X. T., Day, N. P., Pham, T. P., Buurman, W. A., Cardosa, M. J., White, N. J., and Kwiatkowski, D. (1998) Pathophysiologic and prognostic role of cytokines in dengue hemorrhagic fever. J. Infect. Dis. 177, 778–782.

    Article  CAS  PubMed  Google Scholar 

  22. Godfried, M. H., Romijn, J. A., Van der Poll, T., Weverling, G. J., Corssmit, E. P., Endert, E., Eeftinck-Schattenkerk, J. K., and Sauerwein, H. P. (1995) Soluble receptors for tumor necrosis factor are markers for clinical course but not for major metabolic changes in human immunodeficiency virus infection. Metabolism 44, 1564–1569.

    Article  CAS  PubMed  Google Scholar 

  23. Hober, D., Benyoucef, S., Delannoy, A. S., De Groote, D., Ajana, F., Mouton, Y., and Wattre, P. (1996) Plasma levels of sTNFR p75 and IL-8 in patients with HIV-1 infection. Immunol. Lett. 52, 57–60.

    Article  CAS  PubMed  Google Scholar 

  24. Stein, D. S., Lyles, R. H., Graham, N. M., Tassoni, C. J., Margolick, J. B., Phair, J. P., Rinaldo, C., Detels, R., Saah, A., and Bilello, J. (1997) Predicting clinical progression or death in subjects with early-stage human immunodeficiency virus (HIV) infection: a comparative analysis of quantification of HIV RNA, soluble tumor necrosis factor type II receptors, neopterin, and beta2-microglobulin. Multicenter AIDS Cohort Study. J. Infect. Dis. 176, 1161–1167.

    Article  CAS  PubMed  Google Scholar 

  25. Aderka, D., Engelmann, H., Hornik, V., Skornick, Y., Levo, Y., Wallach, D., and Kushtai, G. (1991) Increased serum levels of soluble receptors for tumor necrosis factor in cancer patients. Cancer Res. 51, 5602–5607.

    CAS  PubMed  Google Scholar 

  26. Gadducci, A., Ferdeghini, M., Fanucchi, A., Annicchiarico, C., Prato, B., Prontera, C., Facchini, V., and Genazzani, A. R. (1996) Serum levels of soluble receptors for tumor necrosis factor (p55 and p75 sTNFr) in endometrial cancer. Anticancer Res. 16, 3125–3128.

    CAS  PubMed  Google Scholar 

  27. Staal-Van den Brekel, A. J., Dentener, M. A., Drent, M., Ten Velde, G. P., Buurman, W. A., and Wouters, E. F. (1998) The enhanced inflammatory response in non-small cell lung carcinoma is not reflected in the alveolar compartment. Respir. Med. 92, 76–83.

    Google Scholar 

  28. Elneihoum, A. M., Falke, P., Hedblad, B., Lindgarde, F., and Ohlsson, K. (1997) Leukocyte activation in atherosclerosis: correlation with risk factors. Atherosclerosis 131, 79–84.

    Article  CAS  PubMed  Google Scholar 

  29. Elneihoum, A. M., Falke, P., Axelsson, L., Lundberg, E., Lindgarde, F., and Ohlsson, K. (1996) Leukocyte activation detected by increased plasma levels of inflammatory mediators in patients with ischemic cerebrovascular diseases. Stroke 27, 1734–1738.

    CAS  PubMed  Google Scholar 

  30. Anker, S. D., Clark, A. L., Kemp, M., Salsbury, C., Teixeira, M. M., Hellewell, P. G., and Coats, A. J. (1997) Tumor necrosis factor and steroid metabolism in chronic heart failure: possible relation to muscle wasting. J. Am. Coll. Cardiol. 30, 997–1001.

    Article  CAS  PubMed  Google Scholar 

  31. Tan, L. R., Waxman, K., Scanell, G., Loli, G., and Granger, G. A. (1993) Trauma causes early release of soluble receptors for tumor necrosis factor. J. Trauma 34, 634–638.

    Article  CAS  PubMed  Google Scholar 

  32. Suttmann, U., Ockenga, J., Schneider, H., Selberg, O., Schlesinger, A., Gallati, H., Wolfram, G., Deicher, H., and Muller, M. J. (1996) Weight gain and increased concentrations of receptor proteins for tumor necrosis factor after patients with symptomatic HIV infection received fortified nutrition support. J. Am. Diet. Assoc. 96, 565–569.

    Article  CAS  PubMed  Google Scholar 

  33. Staal-Van den Brekel, A. J., Schols, A. M., Dentener, M. A., Ten Velde, G. P., Buurman, W. A., and Wouters, E. F. (1997) Metabolism in patients with small cell lung carcinoma compared with patients with non-small cell lung carcinoma and healthy controls. Thorax 52, 338–341.

    Google Scholar 

  34. Schols, A. M., Buurman, W. A., Staal-Van den Brekel, A. J., Dentener, M. A., and Wouters, E. F. (1996) Evidence for a relation between metabolic derangements and increased levels of inflammatory mediators in a subgroup of patients with chronic obstructive pulmonary disease. Thorax 51, 819–824.

    Google Scholar 

  35. Staal-Van den Brekel, A. J., Schols, A. M., Dentener, M. A., Ten Velde, G. P., Buurman, W. A., and Wouters, E. F. (1997) The effects of treatment with chemotherapy on energy metabolism and inflammatory mediators in small-cell lung carcinoma. Br. J. Cancer 76, 1630–1635.

    Google Scholar 

  36. Staal-Van den Brekel, A. J., Dentener, M. A., Schols, A. M., Buurman, W. A., and Wouters, E. F. (1995) Increased resting energy expenditure and weight loss are related to a systemic inflammatory response in lung cancer patients. J. Clin. Oncol. 13, 2600–2605.

    Google Scholar 

  37. Aderka, D., Engelmann, H., Maor, Y., Brakebusch, C., and Wallach, D. (1992) Stabilization of the bioactivity of tumor necrosis factor by its soluble receptors. J. Exp. Med. 175, 323–329.

    Article  CAS  PubMed  Google Scholar 

  38. Bazzoni, F. and Beutler, B. (1996) The tumor necrosis factor ligand and receptor families. N. Eng. J. Med. 334, 1717–1725.

    Article  CAS  Google Scholar 

  39. Van Zee, K. J., Kohno, T., Fischer, E., Rock, C. S., Moldawer, L., and Lowry, S. F. (1992) Tumor necrosis factor soluble receptors circulate during experimental and clinical inflammation and can protect against excessive tumor necrosis factor-alpha in vitro and in vivo. Proc. Natl. Acad. Sci. USA 89, 4845–4849.

    Article  PubMed  Google Scholar 

  40. Bemelmans, M. H. A., Gouma, D. J., and Buurman, W. A. (1994) Tissue distribution and clearance of soluble murine TNF receptors in mice. Cytokine 6, 608–615.

    Article  CAS  PubMed  Google Scholar 

  41. Bemelmans, M. H. A., Gouma, D. J., and Buurman, W. A. (1993) Influence of nephrectomy on tumor necrosis factor clearance in a murine model. J. Immunol. 150, 2007–2017.

    CAS  PubMed  Google Scholar 

  42. Peetre, C., Thysell, H., Grubb, A., and Olsson, I. (1988) A tumor necrosis factor binding protein is present in human biological fluids. Eur. J. Haematol. 41, 414–419.

    Article  CAS  PubMed  Google Scholar 

  43. Brockhaus, M., Bar-Khayim, Y., Gurwicz, S., Frensdorff, A., and Haran, N. (1992) Plasma tumor necrosis factor soluble receptors in chronic renal failure. Kidney Int. 42, 663–667.

    Article  CAS  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Department of Surgery, Maastricht University, Maastricht, The Netherlands

    Maarten G. Bouma & Wim A. Buurman

Authors
  1. Maarten G. Bouma
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Wim A. Buurman
    View author publications

    You can also search for this author in PubMed Google Scholar

Editor information

Editors and Affiliations

  1. Imperial College School of Medicine, London, UK

    Thomas J. Evans

Rights and permissions

Reprints and permissions

Copyright information

© 2000 Humana Press Inc.

About this protocol

Cite this protocol

Bouma, M.G., Buurman, W.A. (2000). Assay of Soluble Tumor Necrosis Factor Receptors. In: Evans, T.J. (eds) Septic Shock Methods and Protocols. Methods in Molecular Medicine™, vol 36. Humana Press. https://doi.org/10.1385/1-59259-216-3:91

Download citation

  • DOI: https://doi.org/10.1385/1-59259-216-3:91

  • Publisher Name: Humana Press

  • Print ISBN: 978-0-89603-730-4

  • Online ISBN: 978-1-59259-216-6

  • eBook Packages: Springer Protocols

Publish with us

Policies and ethics

Search

Navigation